Cargando…
Importance of BRCA mutation for the current treatment of pancreatic cancer beyond maintenance
In this editorial, we comment on pancreatic cancer (PC), one of the most aggressive and lethal cancers. Only minimal improvements in survival rates have been achieved over recent years. Available chemotherapeutic regimens have little impact, and surgical resection remains the only reliable curative...
Autores principales: | Martínez-Galán, Joaquina, Rodriguez, Isabel, Caba, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554401/ https://www.ncbi.nlm.nih.gov/pubmed/34754149 http://dx.doi.org/10.3748/wjg.v27.i39.6515 |
Ejemplares similares
-
Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023) -
Pancreatic Cancer: Beyond Brca Mutations
por: Ricci, Vincenzo, et al.
Publicado: (2022) -
Liquid biopsy approach to pancreatic cancer
por: Perales, Sonia, et al.
Publicado: (2021) -
Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018) -
Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020)